In a world where so many individuals have the goal of making their money work for them, investors look to dividend-paying stocks to create a stream of passive income for retirement Sounds great, right? Buy stocks now that will eventually appreciate over time, and create an income stream that should also theoretically grow alongside said
admin
As our trusty authors have covered in detail, electric vehicle (EV) manufacturer Mullen Automotive (NASDAQ:MULN) just received what looks like a $110 million bailout. However, it’s an awfully flimsy lifeline for an automaker that’s in deep financial trouble. If you’re waiting around for MULN stock to recover, don’t hold your breath. It’s entirely possible that
In this article LMT PWSC BK CB A NVDA RUN BAC JNJ GS Follow your favorite stocksCREATE FREE ACCOUNT In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San Anselmo, California. Justin Sullivan | Getty Images Check out the companies making headlines before the bell
A the market returns it’s time to look for the best growth stocks to buy. successful investing strategy partially requires an ability to predict the future. After all, the best growth companies will emerge from trends taking root today. Investors who correctly identify the top growth stocks to buy for the next decade will be
There are plenty of risky dividend-paying stocks with company-specific issues that make them clearly dividend stocks to avoid, but there are also some names in this category where the reason to stay away is not so apparent. One such example is with shares in companies facing possible regulatory scrutiny. This regulatory scrutiny may threaten future
China-based electric vehicle manufacturer Nio (NYSE:NIO) is looking to broaden its scope. However, prospective NIO stock investors should view Nio’s expansion plans with a critical eye. The company’s venture into battery-swapping technology and other fields will require time and capital (both financial and human). In the end, the results might disappoint overeager shareholders. Nio is already
In this article RXDX MTB STT SEDG FSLR ENPH SCHW RBLX MRNA Follow your favorite stocksCREATE FREE ACCOUNT People walk near the Google offices on July 04, 2022 in New York City. John Smith | View Press | Getty Images Check out the companies making headlines in midday trading. State Street, M&T Bank – Shares
With a recession possibly on the horizon, investors may want to consider acquiring stocks with strong balance sheets. Of course, the underlying topic features much debate. According to a Reuters report, the Bank of Canada noted that the risk of recession shrunk. On the other hand, Morgan Stanley reported that U.S. recession risks were rising
Plenty of traders are still willing to risk their hard-earned capital on electric vehicle (EV) manufacturer Lucid Group (NASDAQ:LCID). I wish I could offer them some comfort and a positive outlook. However, LCID stock investors need to prepare for a crash landing. Lucid Group’s recently released results only add to the bearish thesis, unfortunately. Lucid Group’s
As we inch closer to a likely market turnaround, investors set their sights on tech stocks. Cyclicality is a potent market force with a penchant for taking tech stocks to the moon after a painful downturn like last year. Though economic recessions may dampen outlooks for these stocks temporarily, the long-term position for these stocks
Throughout the pandemic, EV stocks soared on the belief that a paradigm shift was underway in the automotive space. Though that continues to hold true, it’s apt at this time to contemplate which EV stocks might be ripe for selling. A myriad of headwinds, including the economic slowdown, supply-chain constraints, and the dwindling geo-political situation, was
Shares in chip maker Intel (NASDAQ:INTC) were hammered throughout 2022, with INTC stock staying on a downward trajectory during the first two months of this year. As I have discussed previously, this was due to two factors. First, the company’s poor financial performance. Second, related to some extent to the first factor, was rising concerns about softening semiconductor
Most analysts agree that the Federal Reserve will likely start to cut rates later this year, and buying stocks of companies that benefit from such a rate-cut environment is a good idea. It’s hard to say whether or not we are at the terminal rate, but I can confidently say that we are pretty close
The markets may be showing solid signs of improvement, but there are still many stocks to sell. In fact, in this environment of elevated interest rates, stocks with unrealistically high valuations are likely to come back to earth sooner rather than later. So, here are seven stocks to sell in April that are very likely to
In many ways, C3.ai (NYSE:AI) stock has been a tale of two valuations over the last year. Before artificial intelligence became the latest fad due to the public’s fascination with ChatGPT, the valuation of AI stock was quite attractive. For example, on Dec. 1, 2022, the shares were changing hands for roughly 3.9 times analysts’ current average
In this article DPZ CZR TXRH COST CRWD Follow your favorite stocksCREATE FREE ACCOUNT Domino’s will roll out 800 custom-branded 2023 Chevy Bolt electric vehicles at locations across the U.S. in the coming months. Domino’s Wall Street analysts are focusing on companies that are well-positioned to navigate the ongoing economic turmoil and emerge stronger. Here
Buying dividend stocks trading at discount pricing is generally a smart idea. Such equities give owners the dual benefit of price appreciation potential in their forward-looking target prices. And two, they also provide nominal income through their periodic dividends. Provided the investor isn’t speculating in high-risk shares, it’s a reasonable strategy overall. Each of the stocks listed
Finding the best pharma stocks to sell can be an all-or-nothing kind of business. If you score on a company making a breakthrough in a new drug or treatment, the rewards can be extreme, but investing in pharma stocks can also mean heavy expenditures on research and testing for a drug that may not perform
Troika Media Group (NASDAQ:TRKA) has been a popular meme stock so far in 2023. Even after tanking following a short squeeze in early March, TRKA stock remains up by more than 135% year-to-date. What makes shares in this marketing company stand out among meme stocks goes beyond just the fact it has been a strong performer.
Adene Sanchez | E+ | Getty Images Company: Exelixis (EXEL) Business: Exelixis, an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. They have produced four marketed pharmaceutical products, including their flagship molecule, cabozantinib. Stock Market Value: $6.3B ($19.46 per share) Activist: Farallon Capital